Back to Results
First PageMeta Content
Technology / Premarket approval / Federal Food /  Drug /  and Cosmetic Act / Medical device / Center for Devices and Radiological Health / Good manufacturing practice / Title 21 of the Code of Federal Regulations / Investigational Device Exemption / Title 21 CFR Part 11 / Food and Drug Administration / Medicine / Health


The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
Add to Reading List

Open Document

File Size: 843,90 KB

Share Result on Facebook

City

Rockville / /

Company

In Vitro Diagnostics / FD&C Act / /

Country

United States / /

/

Event

FDA Phase / /

IndustryTerm

medical device manufacturer / post-amendments device / medical devices / predicate device / manufacturing practices / regulations to require such devices / marketed device / energy source / pre-amendments device / combination products / /

MedicalCondition

injury / illness / disease / /

Organization

U.S. Department of Health and Human Services / office of Communication / Outreach and Development / Food and Drug Administration / Center for Devices and Radiological Health Center for Biologics Evaluation and Research Contains Nonbinding Recommendations Preface Public Comment You / office of Device Evaluation / Center for Devices and Radiological Health / Division of Dockets Management / Food and Drug Administration Center for Devices / office of Combination Products / Task Force on the Utilization of Science / Center for Biologics Evaluation and Research / /

/

Position

General / Secretary / Governor / /

Product

K86-3 / /

ProvinceOrState

Maryland / /

PublishedMedium

the PMA review / /

Technology

pdf / /

URL

http /

SocialTag